Exact Mass: 353.1926

Exact Mass Matches: 353.1926

Found 447 metabolites which its exact mass value is equals to given mass value 353.1926, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Methysergide

(4R,7R)-N-(1-hydroxybutan-2-yl)-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide

C21H27N3O2 (353.2103)


An ergot derivative that is a congener of lysergic acid diethylamide. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. [PubChem] N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CA - Ergot alkaloids D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents KEIO_ID M156; [MS2] KO009047 KEIO_ID M156

   

Levomethadyl Acetate

(1S,4S)-4-(Dimethylamino)-1-ethyl-2,2-diphenylpentyl acetic acid

C23H31NO2 (353.2355)


Levomethadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Opiate receptors (Mu, Kappa, Delta) are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Levomethadyl acetate effectively opens calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist), resulting in hyperpolarization and reduced neuronal excitability. N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   
   

Rosmarinine

Senecionan-11,16-dione, 1,2-dihydro-2,12-dihydroxy-, (1alpha,2alpha)-

C18H27NO6 (353.1838)


   

DEGA

N-(2,6-Dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide

C21H27N3O2 (353.2103)


   
   

Dihydrozeatin riboside

2-(hydroxymethyl)-5-[6-[(4-hydroxy-3-methylbutyl)amino]purin-9-yl]oxolane-3,4-diol

C15H23N5O5 (353.1699)


   

Methadyl Acetate

(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane

C23H31NO2 (353.2355)


Methadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Methadyl Acetate is primarily a mu-type opioid receptor agonist. It functions similarily to methadone. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Olopatadine n-oxide

3-[(2Z)-5-(carboxymethyl)-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-2-ylidene]-N,N-dimethylpropanamine oxide

C21H23NO4 (353.1627)


Olopatadine n-oxide is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)

   

(5E,7E)-Undeca-2,5,7-trienedioylcarnitine

3-[(10-carboxydeca-2,5,7-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H27NO6 (353.1838)


(5E,7E)-Undeca-2,5,7-trienedioylcarnitine is an acylcarnitine. More specifically, it is an (5E,7E)-undeca-2,5,7-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5E,7E)-Undeca-2,5,7-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (5E,7E)-Undeca-2,5,7-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undeca-4,6,8-trienedioylcarnitine

3-[(10-carboxydeca-4,6,8-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H27NO6 (353.1838)


Undeca-4,6,8-trienedioylcarnitine is an acylcarnitine. More specifically, it is an undeca-4,6,8-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-4,6,8-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-4,6,8-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undeca-5,7,9-trienedioylcarnitine

3-[(10-carboxydeca-5,7,9-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H27NO6 (353.1838)


Undeca-5,7,9-trienedioylcarnitine is an acylcarnitine. More specifically, it is an undeca-5,7,9-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-5,7,9-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-5,7,9-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undeca-3,6,9-trienedioylcarnitine

3-[(10-carboxydeca-3,6,9-trienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H27NO6 (353.1838)


Undeca-3,6,9-trienedioylcarnitine is an acylcarnitine. More specifically, it is an undeca-3,6,9-trienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undeca-3,6,9-trienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undeca-3,6,9-trienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine

4-(4-(4-Fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine

C19H20FN5O (353.1652)


   

Cavidine

16,17-Dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaene

C21H23NO4 (353.1627)


   

Epiroprim

5-{[3,5-diethoxy-4-(1H-pyrrol-1-yl)phenyl]methyl}pyrimidine-2,4-diamine

C19H23N5O2 (353.1852)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor

   

Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-

Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-

C18H31N3O4 (353.2314)


   

Proadifen

2-(Diethylamino)ethyl 2,2-diphenylpentanoic acid

C23H31NO2 (353.2355)


   

Dihydropalmatine

2,3,9,10-tetramethoxy-6,8-dihydro-5H-isoquinolino[2,1-b]isoquinoline

C21H23NO4 (353.1627)


Dihydropalmatine is a natural product found in Thalictrum foliolosum with data available. Dihydropalmatine is a alkaloid isolated from Berberis aristata[1].

   

Dehydroglaucine

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,3,5,7,9(17),13,15-heptaene

C21H23NO4 (353.1627)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.323 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.326 Dehydroglaucine is a natural product found in Sarcocapnos saetabensis, Thalictrum ichangense, and other organisms with data available.

   

AB 3217-A

(1R,3S,4S,7R,8R,11R,12R,13R)-8-(4-Methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.03,7]tetradecane-4,12,13-triol

C17H23NO7 (353.1474)


   
   

Thalicthuberine

Thalicthuberine

C21H23NO4 (353.1627)


   

SCHEMBL1066021

SCHEMBL1066021

C19H31NO5 (353.2202)


   
   
   

Brevicompanine C

Brevicompanine C

C21H27N3O2 (353.2103)


   
   

Carbazomadurin A

Carbazomadurin A

C22H27NO3 (353.1991)


   

Neocarazostatin B

Neocarazostatin B

C22H27NO3 (353.1991)


   

3,4-Dehydro-beta-yohimbine

3,4-Dehydro-beta-yohimbine

C21H25N2O3 (353.1865)


   

Platyphylline N-oxide

Platyphylline N-oxide

C18H27NO6 (353.1838)


   

SARRACINE N-OXIDE

SARRACINE N-OXIDE

C18H27NO6 (353.1838)


   
   

Rubropunctamine

9a-Methyl-3-(1-oxohexyl)-6-(1-propenyl)furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione

C21H23NO4 (353.1627)


   

4-Hydroxy-5,8-dimethoxy-2-(3-methoxyphenyl)-3-propylquinoline

4-Hydroxy-5,8-dimethoxy-2-(3-methoxyphenyl)-3-propylquinoline

C21H23NO4 (353.1627)


   
   

JWH 122 N-(4-pentenyl) analog

JWH 122 N-(4-pentenyl) analog

C25H23NO (353.178)


   

proadifen

proadifen

C23H31NO2 (353.2355)


C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor D004791 - Enzyme Inhibitors

   

NCGC00381076-01

NCGC00381076-01

C17H23NO7 (353.1474)


   
   
   

8-Methoxy-uvariopsin|8-Methoxyuvariopsine|[2-(8,9-Dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-aethyl]-dimethyl-amin|[2-(8,9-dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-ethyl]-dimethyl-amine

8-Methoxy-uvariopsin|8-Methoxyuvariopsine|[2-(8,9-Dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-aethyl]-dimethyl-amin|[2-(8,9-dimethoxy-phenanthro[3,4-d][1,3]dioxol-5-yl)-ethyl]-dimethyl-amine

C21H23NO4 (353.1627)


   

cyclostachine B

cyclostachine B

C22H27NO3 (353.1991)


   

7-(4-Hydroxy,3-methoxyphenyl)-N-[(4-butylphenyl)ethyl]propenamide|7-(4-hydroxy-3-methoxyphenyl)-N-[(4-butylphenyl)ethyl]propenamide

7-(4-Hydroxy,3-methoxyphenyl)-N-[(4-butylphenyl)ethyl]propenamide|7-(4-hydroxy-3-methoxyphenyl)-N-[(4-butylphenyl)ethyl]propenamide

C22H27NO3 (353.1991)


   

Hygrophylline

Hygrophylline

C18H27NO6 (353.1838)


   
   

(+)-15-cyanopuupehenone|15-Cyanopuupehenone

(+)-15-cyanopuupehenone|15-Cyanopuupehenone

C22H27NO3 (353.1991)


   

N5,N10-Dibenzoylspermidine

N5,N10-Dibenzoylspermidine

C21H27N3O2 (353.2103)


   

dioxo-3,18 hydroxy-16alpha conatriene-1,4,14

dioxo-3,18 hydroxy-16alpha conatriene-1,4,14

C22H27NO3 (353.1991)


   

(2S-<2alpha,3beta,3<1S*,7aS*>,4alpha>)-<1-(acetoxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl>methyl 3-hydroxy-2,4-dimethyl-5-oxotetrahydrofuran-3-carboxylate|longitubine

(2S-<2alpha,3beta,3<1S*,7aS*>,4alpha>)-<1-(acetoxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl>methyl 3-hydroxy-2,4-dimethyl-5-oxotetrahydrofuran-3-carboxylate|longitubine

C17H23NO7 (353.1474)


   
   

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

C23H31NO2 (353.2355)


   

1-O-beta-D-glucopyranosyladenophorine

1-O-beta-D-glucopyranosyladenophorine

C14H27NO9 (353.1686)


   

13-Methyltetrahydroberberine

13-Methyltetrahydroberberine

C21H23NO4 (353.1627)


   

suaveolindole

suaveolindole

C23H31NO2 (353.2355)


A terpenoid indole alkaloid that is 1H-indole substituted by cyclohexylmethyl ring at position 3 which in turn is substituted by additional methyl groups at positions 2 and 3, a propan-2-ylidene group at position 6 and a 2-carboxyethyl group at position 1. Isolated from Greenwayodendron suaveolens, it exhibits antibacterial activity.

   
   

2,3-Dihydrocapitavine|dihydroxy-5,7 (methyl-1 piperidinyl-2)-6 flavanone

2,3-Dihydrocapitavine|dihydroxy-5,7 (methyl-1 piperidinyl-2)-6 flavanone

C21H23NO4 (353.1627)


   

SCHEMBL13990325

SCHEMBL13990325

C23H31NO2 (353.2355)


   

12,15-dihydroxy-(12alphaH,15betaH)-15,20-dihydro-senecionane-11,16-dione|Bislin|bisline

12,15-dihydroxy-(12alphaH,15betaH)-15,20-dihydro-senecionane-11,16-dione|Bislin|bisline

C18H27NO6 (353.1838)


   

(8,9-dihydroxy)-3-farnesylindole

(8,9-dihydroxy)-3-farnesylindole

C23H31NO2 (353.2355)


   

Carquniostatin B

Carquniostatin B

C21H23NO4 (353.1627)


   

Trichodesmine

Trichodesmine

C18H27NO6 (353.1838)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids

   

5,8-dimethoxy-2-(3-methoxyphenyl)-3-propyl-1h-quinolin-4-one

5,8-dimethoxy-2-(3-methoxyphenyl)-3-propyl-1h-quinolin-4-one

C21H23NO4 (353.1627)


   

N-allyllaurolitsine

N-allyllaurolitsine

C21H23NO4 (353.1627)


   

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

C23H31NO2 (353.2355)


   
   

daphhimalenine A

daphhimalenine A

C22H27NO3 (353.1991)


   

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

C23H31NO2 (353.2355)


   

aniduquinolone C

aniduquinolone C

C21H23NO4 (353.1627)


   
   

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

C23H31NO2 (353.2355)


   

nitrocadambine A

nitrocadambine A

C20H23N3O3 (353.1739)


   

4-[(2,3-Dimethoxy-7,9,10,11,11a,12-hexahydrobenzo[f]pyrrolo[1,2-b]isoquinoline)-6-yl]-2-butanone

4-[(2,3-Dimethoxy-7,9,10,11,11a,12-hexahydrobenzo[f]pyrrolo[1,2-b]isoquinoline)-6-yl]-2-butanone

C22H27NO3 (353.1991)


   

guanacastepene D

guanacastepene D

C22H27NO3 (353.1991)


   

desoxyaxillarine

desoxyaxillarine

C18H27NO6 (353.1838)


   
   

crotolarine lactone

crotolarine lactone

C18H27NO6 (353.1838)


   
   

pseudopalmatine chloride

pseudopalmatine chloride

C21H23NO4 (353.1627)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(+)-7-epi-12-hydroxy-12-oxojasmonoyl-L-isoleucine

(+)-7-epi-12-hydroxy-12-oxojasmonoyl-L-isoleucine

C18H27NO6 (353.1838)


   

Trichodesmine

(3R,4R,5R,8a1R,13aR)-4,5-dihydroxy-3-isopropyl-4,5-dimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione

C18H27NO6 (353.1838)


Trichodesmine is a natural product found in Crotalaria globifera, Crotalaria recta, and other organisms with data available.

   

(8α,9β-Dihydroxy)-3-farnesylindole

(8α,9β-Dihydroxy)-3-farnesylindole

C23H31NO2 (353.2355)


   

Butenafine HCl

Butenafine HCl

C23H28ClN (353.191)


   

N-[2-(4-sec-Butyl-phenoxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl]-acetamide

"NCGC00160345-01!N-[2-(4-sec-Butyl-phenoxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl]-acetamide"

C18H27NO6 (353.1838)


   

putative analog of trichodinA

putative analog of trichodinA

C22H27NO3 (353.1991)


   

C17H23NO7_4-[(2-{[(2-Ethyl-2,3-dihydroxybutanoyl)oxy]methyl}phenyl)amino]-4-oxobutanoic acid

NCGC00381076-01_C17H23NO7_4-[(2-{[(2-Ethyl-2,3-dihydroxybutanoyl)oxy]methyl}phenyl)amino]-4-oxobutanoic acid

C17H23NO7 (353.1474)


   

C17H23NO7_5,8-Epoxy-5H-[1,5]dioxecino[3,2-b]pyrrole-3,6,7-triol, decahydro-11-(4-methoxyphenyl)-, (3S,3aS,5R,6R,7R,8R,11R,11aR)

NCGC00380307-01_C17H23NO7_5,8-Epoxy-5H-[1,5]dioxecino[3,2-b]pyrrole-3,6,7-triol, decahydro-11-(4-methoxyphenyl)-, (3S,3aS,5R,6R,7R,8R,11R,11aR)-

C17H23NO7 (353.1474)


   

4-[2-[(2-ethyl-2,3-dihydroxybutanoyl)oxymethyl]anilino]-4-oxobutanoic acid

4-[2-[(2-ethyl-2,3-dihydroxybutanoyl)oxymethyl]anilino]-4-oxobutanoic acid

C17H23NO7 (353.1474)


   
   
   

methysergide

methysergide

C21H27N3O2 (353.2103)


A synthetic ergot alkaloid, structurally related to the oxytocic agent methylergonovine and to the potent hallucinogen LSD and used prophylactically to reduce the frequency and intensity of severe vascular headaches. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CA - Ergot alkaloids D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   
   
   
   

Fmoc-Leu-OH

N- (9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINE

C21H23NO4 (353.1627)


Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity[1].

   
   

(S)-N-Methylcanadine

(S)-N-Methylcanadine

C21H23NO4 (353.1627)


   

Lys-Val-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-methylpentanoic acid

C16H23N3O6 (353.1587)


   

Val-Lys-OH

(S)-7-amino-2-(3-isopropoxy-4-nitrobenzamido)heptanoic acid

C16H23N3O6 (353.1587)


   

Methadyl acetate

Acetilmetadol [inn-spanish];Acetylmethadol;Acetylmethadolum [inn-latin];Betamethadol

C23H31NO2 (353.2355)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

SPBP 16:0;O2

Hexadecaphinganine-1-phosphate

C16H36NO5P (353.2331)


   

3-[3-(4-tert-butylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

3-[3-(4-tert-butylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

C21H23NO4 (353.1627)


   
   

tert-Butyl (2S,3R)-(+)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate

tert-Butyl (2S,3R)-(+)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate

C21H23NO4 (353.1627)


   

Fmoc-D-Leu-OH

Fmoc-D-Leu-OH

C21H23NO4 (353.1627)


   

Fmoc-D-isoleucine

Fmoc-D-isoleucine

C21H23NO4 (353.1627)


   

Dimemorfan phosphate

Dimemorfan phosphate

C18H28NO4P (353.1756)


   
   

Motretinide

2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-

C23H31NO2 (353.2355)


D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AD - Retinoids for topical use in acne C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

(S)-N-FMOC-alpha-Methylvaline

(S)-N-FMOC-alpha-Methylvaline

C21H23NO4 (353.1627)


   

N-benzy-2-(4-(benzyloxy)phenyl)ethanamine

N-benzy-2-(4-(benzyloxy)phenyl)ethanamine

C22H24ClNO (353.1546)


   

DIMETHYL 2-(1-BENZHYDRYLAZETIDIN-3-YL)MALONATE

DIMETHYL 2-(1-BENZHYDRYLAZETIDIN-3-YL)MALONATE

C21H23NO4 (353.1627)


   

((1S,4S)-4-amino-1-isopropylcyclopent-2-enyl)(3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)Methanone

((1S,4S)-4-amino-1-isopropylcyclopent-2-enyl)(3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)Methanone

C18H22F3N3O (353.1715)


   
   

Fmoc-N-Me-D-Val-OH

Fmoc-N-Me-D-Val-OH

C21H23NO4 (353.1627)


   
   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid

C20H20FN3O2 (353.1539)


   
   

N-BOC-ALPHA-(PHENYLSULFONYL)CYCLOHEXYLMETHYLAMINE

N-BOC-ALPHA-(PHENYLSULFONYL)CYCLOHEXYLMETHYLAMINE

C18H27NO4S (353.1661)


   

Urea, N-cyclohexyl-N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]- (9CI)

Urea, N-cyclohexyl-N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]- (9CI)

C21H27N3O2 (353.2103)


   

1-benzhydryl-3-(benzylamino)azetidine-3-carbonitrile

1-benzhydryl-3-(benzylamino)azetidine-3-carbonitrile

C24H23N3 (353.1892)


   

9-ETHYL-3-[[(2-METHYL-1-INDOLINYL)IMINO]METHY]CARBAZOLE

9-ETHYL-3-[[(2-METHYL-1-INDOLINYL)IMINO]METHY]CARBAZOLE

C24H23N3 (353.1892)


   

N-(2-chloroethyl)-N-methyl-4-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]aniline

N-(2-chloroethyl)-N-methyl-4-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]aniline

C22H26ClN2+ (353.1784)


   

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

C23H31NO2 (353.2355)


   

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

C23H31NO2 (353.2355)


   

3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol

3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol

C19H31NO5 (353.2202)


   

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]norleucine

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]norleucine

C21H23NO4 (353.1627)


   
   

(3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester

(3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester

C19H31NO5 (353.2202)


   

5-[[(4-DIETHYLAMINO)PHENYL]METHYL]-1,4-DIHYDRO-1-METHYL-3-PROPYL-7H-PYRAZOLO[3,4-D]PYRIMIDI-7-ONE

5-[[(4-DIETHYLAMINO)PHENYL]METHYL]-1,4-DIHYDRO-1-METHYL-3-PROPYL-7H-PYRAZOLO[3,4-D]PYRIMIDI-7-ONE

C20H27N5O (353.2215)


   

α-Hydroxy Olopatadine

α-Hydroxy Olopatadine

C21H23NO4 (353.1627)


   

Fmoc-D-Nle-OH

Fmoc-D-Nle-OH

C21H23NO4 (353.1627)


   

Fmoc-D-tert-leucine

Fmoc-D-tert-leucine

C21H23NO4 (353.1627)


   
   

Fmoc-L-allo-Ile-OH

Fmoc-L-allo-Ile-OH

C21H23NO4 (353.1627)


   
   

Benzyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate

Benzyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate

C20H24BNO4 (353.1798)


   

3-aminopropyltris(trimethylsiloxy)silane

3-aminopropyltris(trimethylsiloxy)silane

C12H35NO3Si4 (353.1694)


   

Benzyltriphenylphosphonium iodide

Benzyltriphenylphosphonium iodide

C25H22P+ (353.1459)


   

N-(4-(Dimethylamino)phenethyl)-3-ethyl-5-fluoro-1H-indole-2-carboxamide

N-(4-(Dimethylamino)phenethyl)-3-ethyl-5-fluoro-1H-indole-2-carboxamide

C21H24FN3O (353.1903)


   

4-CYCLOHEXYL-1-(4-METHYLPHENYLSULFONYL)INDOLE

4-CYCLOHEXYL-1-(4-METHYLPHENYLSULFONYL)INDOLE

C21H23NO2S (353.1449)


   

2-(1-trityl-1H-imidazol-4-yl)ethanamine

2-(1-trityl-1H-imidazol-4-yl)ethanamine

C24H23N3 (353.1892)


   

Dioxaphetyl butyrate

ethyl 4-morpholin-4-yl-2,2-diphenylbutanoate

C22H27NO3 (353.1991)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

Fmoc-D-Allo-Ile-OH

Fmoc-D-Allo-Ile-OH

C21H23NO4 (353.1627)


   

20-isocyanato-2,5,8,11,14,17-hexaoxabicyclo[16.4.0]docosa-1(18),19,21-triene

20-isocyanato-2,5,8,11,14,17-hexaoxabicyclo[16.4.0]docosa-1(18),19,21-triene

C17H23NO7 (353.1474)


   
   

Fmoc-L-beta-homovaline

Fmoc-L-beta-homovaline

C21H23NO4 (353.1627)


   

Oxpheneridine

Oxpheneridine

C22H27NO3 (353.1991)


   
   
   

TERT-BUTYL 6-OXO-2 3-DIPHENYL-4-

TERT-BUTYL 6-OXO-2 3-DIPHENYL-4-

C21H23NO4 (353.1627)


   

(R)-Di-2-naphthylprolinol

(R)-Di-2-naphthylprolinol

C25H23NO (353.178)


   

2-(trifluoromethyl)--1H-Pyrrolo[2,3-b]pyridin-5-amine

2-(trifluoromethyl)--1H-Pyrrolo[2,3-b]pyridin-5-amine

C21H23NO4 (353.1627)


   

N-Fmoc-N-(2-methylpropyl)glycine

N-Fmoc-N-(2-methylpropyl)glycine

C21H23NO4 (353.1627)


   

Betacetylmethadol

[(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate

C23H31NO2 (353.2355)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Olopatadine N-Oxide

Olopatadine N-Oxide

C21H23NO4 (353.1627)


   

Drofenine hydrochloride

Drofenine hydrochloride

C20H32ClNO2 (353.2121)


   

Fmoc-N-Me-Val-OH

Fmoc-N-Me-Val-OH

C21H23NO4 (353.1627)


   

1-benzyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydropyridin-4-one

1-benzyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydropyridin-4-one

C21H23NO4 (353.1627)


   

(S)-DINAPHTHALEN-2-YL(PYRROLIDIN-2-YL)METHANOL

(S)-DINAPHTHALEN-2-YL(PYRROLIDIN-2-YL)METHANOL

C25H23NO (353.178)


   

(R)-N-FMOC-alpha-Methylvaline

(R)-N-FMOC-alpha-Methylvaline

C21H23NO4 (353.1627)


   

3-(Morpholinosulfonyl)phenylboronic acid pinacol ester

3-(Morpholinosulfonyl)phenylboronic acid pinacol ester

C16H24BNO5S (353.1468)


   
   

6-(Triethoxysilyl)-1-hexanesulfonyl azide

6-(Triethoxysilyl)-1-hexanesulfonyl azide

C12H27N3O5SSi (353.1441)


   

Fmoc-N-Me-Nva-OH

Fmoc-N-Me-Nva-OH

C21H23NO4 (353.1627)


   
   

Benzoicacid, 2-[4-(cyclohexylmethylamino)-2-hydroxybenzoyl]-

Benzoicacid, 2-[4-(cyclohexylmethylamino)-2-hydroxybenzoyl]-

C21H23NO4 (353.1627)


   

SULFUR AA STANDARD

SULFUR AA STANDARD

C18H27NO4S (353.1661)


   

Fmoc-6-Aminohexanoic Acid

Fmoc-6-Aminohexanoic Acid

C21H23NO4 (353.1627)


   

TERT-BUTYL 4-(BENZYLOXY)-3-(HYDROXYMETHYL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 4-(BENZYLOXY)-3-(HYDROXYMETHYL)-1H-INDOLE-1-CARBOXYLATE

C21H23NO4 (353.1627)


   

Alphacetylmethadol

(3R,6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanyl acetate

C23H31NO2 (353.2355)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Butenafine hydrochloride

Butenafine hydrochloride

C23H28ClN (353.191)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Butenafine Hydrochloride (KP363 Hydrochloride) is a synthetic benzylamine antifungal, works by inhibiting the synthesis of sterols by inhibiting squalene epoxidase.

   

Tert-butyl-(2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate

Tert-butyl-(2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate

C21H23NO4 (353.1627)


   

n-(9-fluorenylmethoxycarbonyl)-l-leucin&

n-(9-fluorenylmethoxycarbonyl)-l-leucin&

C21H23NO4 (353.1627)


   

N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C

N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C

C21H23NO4 (353.1627)


   

NH2-PEG6-CH2CH2COOH

NH2-PEG6-CH2CH2COOH

C15H31NO8 (353.205)


   

NS-11394

NS-11394

C23H19N3O (353.1528)


NS11394 is an orally active and unique subtype-selective GABAA positive allosteric receptor (PAM), with a Ki of ~0.5 nM. NS11394 shows a selectivity profile in the order of GABAA-5 > α3 > α2 > α1-containing receptors. NS11394 has anxiolytic and anti-inflammatory properties[1][2][3].

   

(s)-o-tolyl-cbs-oxazaborolidine, 0.5m i&

(s)-o-tolyl-cbs-oxazaborolidine, 0.5m i&

C24H24BNO (353.1951)


   

(r)-o-tolyl-cbs-oxazaborolidine, 0.5m i&

(r)-o-tolyl-cbs-oxazaborolidine, 0.5m i&

C24H24BNO (353.1951)


   

methyl 2-methylprop-2-enoate,2-(1-oxa-4-azaspiro[4.5]decan-4-yl)ethyl 2-methylprop-2-enoate

methyl 2-methylprop-2-enoate,2-(1-oxa-4-azaspiro[4.5]decan-4-yl)ethyl 2-methylprop-2-enoate

C19H31NO5 (353.2202)


   

Imidazo(1,2-b)pyridazine, 3-(6-(2-methoxyethyl)-3-pyridinyl)-2-methyl-8-(4-morpholinyl)-

Imidazo(1,2-b)pyridazine, 3-(6-(2-methoxyethyl)-3-pyridinyl)-2-methyl-8-(4-morpholinyl)-

C19H23N5O2 (353.1852)


   

Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone

Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone

C19H23N5S (353.1674)


   

3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1H-pyridin-2-one

3-[(2E,4E)-4,6-dimethylocta-2,4-dienoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1H-pyridin-2-one

C21H23NO4 (353.1627)


   

2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid

2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid

C21H23NO4 (353.1627)


   

N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]cyclohexanecarboxamide

N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]cyclohexanecarboxamide

C21H27N3O2 (353.2103)


   

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester

2-(3,5-Dimethyl-1-pyrazolyl)-4-(4-hydroxyanilino)-5-pyrimidinecarboxylic acid ethyl ester

C18H19N5O3 (353.1488)


   
   

2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone

2-(1,2-Dihydroimidazo[1,2-a]benzimidazol-4-yl)-1-(4-phenylphenyl)ethanone

C23H19N3O (353.1528)


   

1-ethyl-2-[(1E,3Z)-3-(1-ethylquinolin-2(1H)-ylidene)prop-1-en-1-yl]quinolinium

1-ethyl-2-[(1E,3Z)-3-(1-ethylquinolin-2(1H)-ylidene)prop-1-en-1-yl]quinolinium

C25H25N2+ (353.2018)


   

5-Amino-1-Tert-Butyl-3-(7-Ethoxyquinolin-3-Yl)-1h-Pyrazole-4-Carboxamide

5-Amino-1-Tert-Butyl-3-(7-Ethoxyquinolin-3-Yl)-1h-Pyrazole-4-Carboxamide

C19H23N5O2 (353.1852)


   

Serine-3-aminoadenosine

Serine-3-aminoadenosine

C13H19N7O5 (353.1448)


   

(4R,16R)-5,6-dihydroxy-5,6-dimethyl-4-propan-2-yl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione

(4R,16R)-5,6-dihydroxy-5,6-dimethyl-4-propan-2-yl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

Enzaprost F

Enzaprost F

C20H33O5- (353.2328)


D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

16-Hydroxytabersoninium

16-Hydroxytabersoninium

C21H25N2O3+ (353.1865)


The indole alkaloid cation that is the conjugate acid of 16-hydroxytabersonine, arising from protonation of the tertiary amino function; major species at pH 7.3.

   

prostaglandin E1(1-)

prostaglandin E1(1-)

C20H33O5- (353.2328)


Conjugate base of prostaglandin E1.

   

(3R)-1,2-didehydro-3-hydroxy-2,3-dihydrotabersonine

(3R)-1,2-didehydro-3-hydroxy-2,3-dihydrotabersonine

C21H25N2O3+ (353.1865)


   

methyl (1R,10S,11S,12E,17S)-12-ethylidene-10-(hydroxymethyl)-8-aza-14-azoniapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,8-tetraene-10-carboxylate

methyl (1R,10S,11S,12E,17S)-12-ethylidene-10-(hydroxymethyl)-8-aza-14-azoniapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,8-tetraene-10-carboxylate

C21H25N2O3+ (353.1865)


   
   

(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

C20H33O5- (353.2328)


   

N-[[(1R)-3-Oxo-2alpha-[(2Z)-5-hydroxy-5-oxo-2-pentenyl]cyclopentane-1alpha-yl]acetyl]-L-isoleucine

N-[[(1R)-3-Oxo-2alpha-[(2Z)-5-hydroxy-5-oxo-2-pentenyl]cyclopentane-1alpha-yl]acetyl]-L-isoleucine

C18H27NO6 (353.1838)


   

Undeca-4,6,8-trienedioylcarnitine

Undeca-4,6,8-trienedioylcarnitine

C18H27NO6 (353.1838)


   

Undeca-5,7,9-trienedioylcarnitine

Undeca-5,7,9-trienedioylcarnitine

C18H27NO6 (353.1838)


   

Undeca-3,6,9-trienedioylcarnitine

Undeca-3,6,9-trienedioylcarnitine

C18H27NO6 (353.1838)


   

(5E,7E)-Undeca-2,5,7-trienedioylcarnitine

(5E,7E)-Undeca-2,5,7-trienedioylcarnitine

C18H27NO6 (353.1838)


   

1-ethyl-2-[3-(1-ethylquinolin-2(1H)-ylidene)prop-1-en-1-yl]quinolinium

1-ethyl-2-[3-(1-ethylquinolin-2(1H)-ylidene)prop-1-en-1-yl]quinolinium

C25H25N2+ (353.2018)


   

Thalictricavine

Thalictricavine

C21H23NO4 (353.1627)


A natural product found in Corydalis cava.

   

Antibiotic AB3217A

Antibiotic AB3217A

C17H23NO7 (353.1474)


   

11-epi-prostaglandin F2alpha(1-)

11-epi-prostaglandin F2alpha(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of 11-epi-prostaglandin F2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

1-[(2E,4E,10E)-10-(3,4-methylenedioxyphenyl)-2,4,10-undecatrienoyl]pyrrolidine

1-[(2E,4E,10E)-10-(3,4-methylenedioxyphenyl)-2,4,10-undecatrienoyl]pyrrolidine

C22H27NO3 (353.1991)


A natural product found in Piper boehmeriaefolium.

   

Cuscuta propenamide 2

Cuscuta propenamide 2

C22H27NO3 (353.1991)


An enamide obtained by the formal condensation of ferulic acid with 2-(4-butylphenyl)ethanamine. It is isolated from Cuscuta reflexa and displays strong inhibitory activity against alpha-glucosidase (EC 3.2.1.20).

   

Ajmalicine(1+)

Ajmalicine(1+)

C21H25N2O3+ (353.1865)


An ammonium ion resulting from the protonation of the tertiary amino group of ajmalicine. The major species at pH 7.3.

   

prostaglandin H1(1-)

prostaglandin H1(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin H1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Tetrahydroalstonine(1+)

Tetrahydroalstonine(1+)

C21H25N2O3+ (353.1865)


An ammonium ion resulting from the protonation of the tertiary amino group of tetrahydroalstonine. The major microspecies at pH 7.3.

   

prostaglandin D1(1-)

prostaglandin D1(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

4-(butan-2-yl)phenyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside

4-(butan-2-yl)phenyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside

C18H27NO6 (353.1838)


   

4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione

C20H23N3OS (353.1562)


   

(4E)-1-ethyl-4-[(E)-3-(1-ethylquinolin-1-ium-4-yl)prop-2-enylidene]quinoline

(4E)-1-ethyl-4-[(E)-3-(1-ethylquinolin-1-ium-4-yl)prop-2-enylidene]quinoline

C25H25N2+ (353.2018)


   

2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide

2-(3,5-dimethyl-4-nitro-1-pyrazolyl)-N-[(2-methyl-4-quinolinyl)methyl]acetamide

C18H19N5O3 (353.1488)


   

(5Z,9E,12S,14Z)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

(5Z,9E,12S,14Z)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

C20H33O5- (353.2328)


Conjugate base of (5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.

   
   

trioxilin A3(1-)

trioxilin A3(1-)

C20H33O5- (353.2328)


The trioxilin anion that is the anion formed from trioxilin A3 by deprotonation of its carboxylic acid moiety; major microspecies present at pH 7.3.

   

trioxilin B3(1-)

trioxilin B3(1-)

C20H33O5- (353.2328)


The trioxilin anion that is the anion formed from trioxilin B3 by deprotonation of its carboxylic acid moiety; major microspecies present at pH 7.3.

   

1-[(1-tert-butyl-5-tetrazolyl)-thiophen-2-ylmethyl]-3,4-dihydro-2H-quinoline

1-[(1-tert-butyl-5-tetrazolyl)-thiophen-2-ylmethyl]-3,4-dihydro-2H-quinoline

C19H23N5S (353.1674)


   

2-cyano-N-(3-methoxypropyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide

2-cyano-N-(3-methoxypropyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide

C19H23N5O2 (353.1852)


   

2-[[2-[(2-Fluorophenyl)methoxy]-3-methoxyphenyl]methylamino]phenol

2-[[2-[(2-Fluorophenyl)methoxy]-3-methoxyphenyl]methylamino]phenol

C21H20FNO3 (353.1427)


   

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide

N-hydroxy-N-[(E)-(4-hydroxy-2,6-dimethoxyphenyl)methylideneamino]heptanediamide

C16H23N3O6 (353.1587)


   

N-[(4-methylphenyl)methyl]-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine

N-[(4-methylphenyl)methyl]-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine

C22H19N5 (353.164)


   

13,14-dihydrolipoxin A4(1-)

13,14-dihydrolipoxin A4(1-)

C20H33O5- (353.2328)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 13,14-dihydrolipoxin A4; major species at pH 7.3.

   

15-ketoprostaglandin F1alpha(1-)

15-ketoprostaglandin F1alpha(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of 15-ketoprostaglandin F1alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

1-(4-Ethylphenyl)-3-[1-(phenylmethyl)-4-piperidinyl]thiourea

1-(4-Ethylphenyl)-3-[1-(phenylmethyl)-4-piperidinyl]thiourea

C21H27N3S (353.1926)


   

N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide

N-Pyridin-2-yl-3-(o-tolylaminooxalyl-hydrazono)-butyramide

C18H19N5O3 (353.1488)


   

N-[2-(dipropylamino)ethyl]-4-methyl-2-furo[3,2-c]quinolinecarboxamide

N-[2-(dipropylamino)ethyl]-4-methyl-2-furo[3,2-c]quinolinecarboxamide

C21H27N3O2 (353.2103)


   

(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide

(E)-2-cyano-3-[2-(2,6-dimethylmorpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide

C18H19N5O3 (353.1488)


   

Pinacyanol cation

Pinacyanol cation

C25H25N2+ (353.2018)


   

(5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oate

(5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oate

C20H33O5- (353.2328)


   

2-Methoxy-4-[5-methyl-3-(2-oxolanylmethylamino)-2-imidazo[1,2-a]pyridinyl]phenol

2-Methoxy-4-[5-methyl-3-(2-oxolanylmethylamino)-2-imidazo[1,2-a]pyridinyl]phenol

C20H23N3O3 (353.1739)


   

11alpha-Hydroxy-9,15-dioxoprostan-1-oate

11alpha-Hydroxy-9,15-dioxoprostan-1-oate

C20H33O5- (353.2328)


   

Lochnericine(1+)

Lochnericine(1+)

C21H25N2O3+ (353.1865)


An ammonium ion derivative resulting from the protonation of the tertiary amino group of lochnericine. The major species at pH 7.3.

   

(3,4-Dimethoxyphenyl)-[1-(2-phenylethyl)-3-piperidinyl]methanone

(3,4-Dimethoxyphenyl)-[1-(2-phenylethyl)-3-piperidinyl]methanone

C22H27NO3 (353.1991)


   

4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol

4-[(5-Methyl-2,4-diphenyl-2H-pyrazol-3-ylimino)-methyl]-phenol

C23H19N3O (353.1528)


   

1,3-Bis-(1-ethyl-[4]quinolyl)-trimethinium

1,3-Bis-(1-ethyl-[4]quinolyl)-trimethinium

C25H25N2+ (353.2018)


   

(-)-(R)-19-hydroxytabersonine

(-)-(R)-19-hydroxytabersonine

C21H25N2O3+ (353.1865)


   

N-acetyl-1-[(2R)-5-hydroxy-2-pentyltetrahydrofuran-3-yl]-L-histidine

N-acetyl-1-[(2R)-5-hydroxy-2-pentyltetrahydrofuran-3-yl]-L-histidine

C17H27N3O5 (353.1951)


   
   
   
   

prostaglandin F2beta(1-)

prostaglandin F2beta(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin F2beta, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(2S,3S,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2S,3S,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine

4-[2-[[1-(Phenylmethyl)-2-benzimidazolyl]thio]ethyl]morpholine

C20H23N3OS (353.1562)


   

N-[[3-(4-methylphenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

N-[[3-(4-methylphenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

C24H23N3 (353.1892)


   

1-ethenyl-6,7-dimethoxy-2-[(4-methoxyphenyl)methyl]-3-methyl-3,4-dihydro-1H-isoquinoline

1-ethenyl-6,7-dimethoxy-2-[(4-methoxyphenyl)methyl]-3-methyl-3,4-dihydro-1H-isoquinoline

C22H27NO3 (353.1991)


   

(4E)-1-ethyl-4-[(Z)-3-(1-ethylquinolin-1-ium-4-yl)prop-2-enylidene]quinoline

(4E)-1-ethyl-4-[(Z)-3-(1-ethylquinolin-1-ium-4-yl)prop-2-enylidene]quinoline

C25H25N2+ (353.2018)


   

Astepyrazinoxide

Astepyrazinoxide

C20H23N3O3 (353.1739)


   

N-cyclohexyl-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

(2S,3S,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2S,3S,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

(2R,3S,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2R,3S,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

(2R,3S,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2R,3S,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

(2S,3R,4R)-2-cyano-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-N-propylazetidine-1-carboxamide

(2S,3R,4R)-2-cyano-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-N-propylazetidine-1-carboxamide

C21H27N3O2 (353.2103)


   

N-cyclohexyl-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-cyclohexyl-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-cyclohexyl-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-propylacetamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-propylacetamide

C21H27N3O2 (353.2103)


   

(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C21H24FN3O (353.1903)


   

N-cyclohexyl-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-cyclohexyl-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-cyclohexyl-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

N-cyclohexyl-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.2314)


   

(2R,3R,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2R,3R,4S)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

(2R,3R,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

(2R,3R,4R)-2-cyano-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-N-propyl-1-azetidinecarboxamide

C21H27N3O2 (353.2103)


   

N-[[(2S,3R,4R)-4-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylpropanamide

N-[[(2S,3R,4R)-4-(hydroxymethyl)-3-phenyl-1-(3-pyridinylmethyl)-2-azetidinyl]methyl]-N-methylpropanamide

C21H27N3O2 (353.2103)


   

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-propylacetamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinyl]methyl]-N-propylacetamide

C21H27N3O2 (353.2103)


   

(1S,5R)-7-[4-(3-fluorophenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1S,5R)-7-[4-(3-fluorophenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C21H24FN3O (353.1903)


   

2-(dimethylamino)-1-[(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-(dimethylamino)-1-[(1S,5R)-7-[4-(2-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C21H24FN3O (353.1903)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

8-epi-prostaglandin F2alpha(1-)

8-epi-prostaglandin F2alpha(1-)

C20H33O5- (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of 8-epi-prostaglandin F2alpha, obtained by deprotonation of the carboxy group. Major structure at pH 7.3.

   
   

(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoate

(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoate

C20H33O5- (353.2328)


   

11,12,15-trihydroxyeicosa-(5Z,8Z,13E)-trienoate

11,12,15-trihydroxyeicosa-(5Z,8Z,13E)-trienoate

C20H33O5- (353.2328)


   

13,14,15-trihydroxyeicosa-(5Z,8Z,11Z)-trienoate

13,14,15-trihydroxyeicosa-(5Z,8Z,11Z)-trienoate

C20H33O5- (353.2328)


   

2-phenyl-3-[(S)-pyridin-2-yl(pyrrolidin-1-yl)methyl]-1H-indole

2-phenyl-3-[(S)-pyridin-2-yl(pyrrolidin-1-yl)methyl]-1H-indole

C24H23N3 (353.1892)


   
   

Monascaminone methyl ether

Monascaminone methyl ether

C23H31NO2 (353.2355)


   

5-(2-Acetoxyethylamino)-3-methoxy-2,6-dimethyl-(6R*)-((2R*)-2-methylbutyryloxy)-2,4-cyclohexadien-1-one

5-(2-Acetoxyethylamino)-3-methoxy-2,6-dimethyl-(6R*)-((2R*)-2-methylbutyryloxy)-2,4-cyclohexadien-1-one

C18H27NO6 (353.1838)


   

4-(3-(4-(2-Trimethylsilyloxyethoxy)phenoxy)propyl)morphorine

4-(3-(4-(2-Trimethylsilyloxyethoxy)phenoxy)propyl)morphorine

C18H31NO4Si (353.2022)


   

alpha-(4-Dimethylaminophenyl)-omega-(9-phenanthryl)butane

alpha-(4-Dimethylaminophenyl)-omega-(9-phenanthryl)butane

C26H27N (353.2143)


   

3-[[2-(Benzoylamino)phenyl]thio]-5,5-dimethyl-1-cyclohexanone

3-[[2-(Benzoylamino)phenyl]thio]-5,5-dimethyl-1-cyclohexanone

C21H23NO2S (353.1449)


   

2-(3-Trimethylsilyloxybutoxy)-N-[2-(ethylamino)ethyl]-3-pyridinecarboxamide

2-(3-Trimethylsilyloxybutoxy)-N-[2-(ethylamino)ethyl]-3-pyridinecarboxamide

C17H31N3O3Si (353.2135)


   

(6R,6aS,8R,10S,10aR)-4-(4-hydroxyphenyl)-6,6a,8,10-tetramethyl-6,7,8,9,10,10a-hexahydro-2H-isochromeno[4,3-c]pyridin-1-one

(6R,6aS,8R,10S,10aR)-4-(4-hydroxyphenyl)-6,6a,8,10-tetramethyl-6,7,8,9,10,10a-hexahydro-2H-isochromeno[4,3-c]pyridin-1-one

C22H27NO3 (353.1991)


   
   

Levacetylmethadol

Levomethadyl Acetate

C23H31NO2 (353.2355)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

1-Methyllysergic acid butanolamide

1-Methyllysergic acid butanolamide

C21H27N3O2 (353.2103)


   

prostaglandin F2alpha(1-)

prostaglandin F2alpha(1-)

C20H33O5 (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin F2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Deseril

Deseril

C21H27N3O2 (353.2103)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

13,14-dihydro-15-oxoprostaglandin E1(1-)

13,14-dihydro-15-oxoprostaglandin E1(1-)

C20H33O5 (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-oxoprostaglandin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

C16 Sphinganine-1-phosphate

C16 Sphinganine-1-phosphate

C16H36NO5P (353.2331)


   
   

11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoate

11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoate

C20H33O5 (353.2328)


A trihydroxyicosatrienoate that is the conjugate base of 11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-(1-hydroxybutan-2-yl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide

N-(1-hydroxybutan-2-yl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide

C21H27N3O2 (353.2103)


   

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide

C21H27N3O2 (353.2103)


   

11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoate(1-)

11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoate(1-)

C20H33O5 (353.2328)


A trihydroxyicosatrienoate that is the conjugate base of 11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13,14-dihydro-15-keto-PGF2alpha(1-)

13,14-dihydro-15-keto-PGF2alpha(1-)

C20H33O5 (353.2328)


A prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-keto-PGF2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   

C16 Sphinganine 1-phosphate

C16 Sphinganine 1-phosphate

C16H36NO5P (353.2331)


   

ESI-08

ESI-08

C20H23N3OS (353.1562)


ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation[1].

   

FATP1-IN-2

FATP1-IN-2

C19H20FN5O (353.1652)


FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 (FATP1) inhibitor (human IC50=0.43 μM, mouse IC50=0.39 μM)[1].

   

ML337

ML337

C21H20FNO3 (353.1427)


ML337 is a selective and brain-penetrant negative allosteric modulator of mGlu3, with an IC50 of 593 nM. ML337 possesses a favorable dystrophia myotonica protein kinase (DMPK) and ancillary pharmacology profile[1]. ML337 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

PRE-084 (hydrochloride)

PRE-084 (hydrochloride)

C19H28ClNO3 (353.1758)


PRE-084 hydrochloride is a highly selective σ1 receptor (S1R) agonist, with an IC50 of 44 nM. PRE-084 hydrochloride exhibits good neuroprotective effects, can improve motor function and motor neuron survival in mice. PRE-084 hydrochloride also can ameliorate myocardial ischemia-reperfusion injury in rats by activating the Akt-eNOS pathway[1][2][3][4].

   

2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h,11ah,11bh-naphtho[2,3-a]pyrrolizine-3,11-dione

2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h,11ah,11bh-naphtho[2,3-a]pyrrolizine-3,11-dione

C20H23N3O3 (353.1739)


   

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methyl-5-oxopyrrolidine-2-carboxylate

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methyl-5-oxopyrrolidine-2-carboxylate

C19H28ClNO3 (353.1758)


   

4-ethylidene-7-hydroxy-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-14-ium-14-olate

4-ethylidene-7-hydroxy-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-14-ium-14-olate

C18H27NO6 (353.1838)


   

(9ar)-3-hexanoyl-9a-methyl-6-[(1e)-prop-1-en-1-yl]-7h-furo[3,2-g]isoquinoline-2,9-dione

(9ar)-3-hexanoyl-9a-methyl-6-[(1e)-prop-1-en-1-yl]-7h-furo[3,2-g]isoquinoline-2,9-dione

C21H23NO4 (353.1627)


   

(1r,4s,6r,7r,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4s,6r,7r,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H27NO6 (353.1838)


   

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)-2-methoxyphenol

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)-2-methoxyphenol

C20H23N3O3 (353.1739)


   

(1r,4s,6r,7s,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4s,6r,7s,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H27NO6 (353.1838)


   

(1r,4r,5r,6r,16r)-5,6-dihydroxy-4-isopropyl-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4r,5r,6r,16r)-5,6-dihydroxy-4-isopropyl-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

1-(1,2-dihydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

1-(1,2-dihydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

C21H23NO4 (353.1627)


   

(1r,4r,5s,6s,16s)-6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4r,5s,6s,16s)-6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

7-{[(2,3-dihydroxy-2-methylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

7-{[(2,3-dihydroxy-2-methylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

C18H27NO6 (353.1838)


   

(12s,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

(12s,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

C21H23NO4 (353.1627)


   

1-[(1r,2s,4as,8as)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

1-[(1r,2s,4as,8as)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

C22H27NO3 (353.1991)


   

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

C23H31NO2 (353.2355)


   

2,3-dimethoxy-6-(3-oxo-butyl)-7,9,10,11,11a,12-hexahydrobenzo[ f ]pyrrolo[1,2-b ]isoquinoline

NA

C22H27NO3 (353.1991)


{"Ingredient_id": "HBIN004056","Ingredient_name": "2,3-dimethoxy-6-(3-oxo-butyl)-7,9,10,11,11a,12-hexahydrobenzo[ f ]pyrrolo[1,2-b ]isoquinoline","Alias": "NA","Ingredient_formula": "C22H27NO3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6271","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,4s,5r,6r,16r)-6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4s,5r,6r,16r)-6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

(1r,7ar)-7-({[(2s,3s)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

(1r,7ar)-7-({[(2s,3s)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

C18H27NO6 (353.1838)


   

4-ethylidene-5,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

4-ethylidene-5,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

6-ethyl-5,6-dihydroxy-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

[7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C17H23NO7 (353.1474)


   

16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene

16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene

C21H23NO4 (353.1627)


   

1-[(2r)-2-hydroxypropyl]-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-4-ol

1-[(2r)-2-hydroxypropyl]-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-4-ol

C22H27NO3 (353.1991)


   

3-(1-hydroxyhexylidene)-9a-methyl-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinoline-2,9-dione

3-(1-hydroxyhexylidene)-9a-methyl-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinoline-2,9-dione

C21H23NO4 (353.1627)


   

(12r,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

(12r,13r)-16,17-dimethoxy-12-methyl-5,7-dioxa-1-azapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10,14(19),15,17-hexaene

C21H23NO4 (353.1627)


   

(1s,4s,7r,7ar)-1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

(1s,4s,7r,7ar)-1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

C18H27NO6 (353.1838)


   

methyl (1s,9r,12r,13e)-13-ethylidene-18-(hydroxymethyl)-15-azapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

methyl (1s,9r,12r,13e)-13-ethylidene-18-(hydroxymethyl)-15-azapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C22H27NO3 (353.1991)


   

(1s,12s,15s,17r,20r)-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

(1s,12s,15s,17r,20r)-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

C23H31NO2 (353.2355)


   

3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol

3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol

C21H23NO4 (353.1627)


   

4-{4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl}but-3-en-2-ol

4-{4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl}but-3-en-2-ol

C22H27NO3 (353.1991)


   

7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid

7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid

C21H23NO4 (353.1627)


   

6-hydroxy-6-(1-hydroxyethyl)-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

6-hydroxy-6-(1-hydroxyethyl)-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

methyl 6-methyl-20-oxo-8-azapentacyclo[11.5.1.1⁵,⁸.0²,¹⁰.0¹⁶,¹⁹]icosa-1,3,13(19)-triene-17-carboxylate

methyl 6-methyl-20-oxo-8-azapentacyclo[11.5.1.1⁵,⁸.0²,¹⁰.0¹⁶,¹⁹]icosa-1,3,13(19)-triene-17-carboxylate

C22H27NO3 (353.1991)


   

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methyl-5-oxopyrrolidine-2-carboxylate

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methyl-5-oxopyrrolidine-2-carboxylate

C19H28ClNO3 (353.1758)


   

4-[(3,4-dimethoxyphenyl)methyl]-1-[(4-methoxyphenyl)methyl]-3h-imidazol-2-imine

4-[(3,4-dimethoxyphenyl)methyl]-1-[(4-methoxyphenyl)methyl]-3h-imidazol-2-imine

C20H23N3O3 (353.1739)


   

(1r,4s,5s,6r,16r)-5,6-dihydroxy-4-isopropyl-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4s,5s,6r,16r)-5,6-dihydroxy-4-isopropyl-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

(3e)-5-{2,6-dimethyl-5-oxopyrano[3,2-c]quinolin-2-yl}-2,2-dimethylpent-3-enoic acid

(3e)-5-{2,6-dimethyl-5-oxopyrano[3,2-c]quinolin-2-yl}-2,2-dimethylpent-3-enoic acid

C21H23NO4 (353.1627)


   

1-(2-hydroxypropyl)-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-4-ol

1-(2-hydroxypropyl)-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-4-ol

C22H27NO3 (353.1991)


   

3-hexanoyl-9a-methyl-6-(prop-1-en-1-yl)-7h-furo[3,2-g]isoquinoline-2,9-dione

3-hexanoyl-9a-methyl-6-(prop-1-en-1-yl)-7h-furo[3,2-g]isoquinoline-2,9-dione

C21H23NO4 (353.1627)


   

(2e,4z,6e)-7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid

(2e,4z,6e)-7-{12-hydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),9,11-tetraen-3-yl}-4-methoxy-6-methylhepta-2,4,6-trienimidic acid

C21H23NO4 (353.1627)


   

6-hydroxy-4-isopropyl-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6-hydroxy-4-isopropyl-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C21H27N3O2 (353.2103)


   

(3s,4s)-3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol

(3s,4s)-3-methoxy-6-(3-methylbut-2-en-1-yl)-4-phenyl-3h-quinoline-2,4,5-triol

C21H23NO4 (353.1627)


   

(1s,4r,7s,9r)-6-hydroxy-4-isopropyl-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4r,7s,9r)-6-hydroxy-4-isopropyl-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C21H27N3O2 (353.2103)


   

(4r,7r)-n-(1-hydroxybutan-2-yl)-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

(4r,7r)-n-(1-hydroxybutan-2-yl)-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

C21H27N3O2 (353.2103)


   

(2e,4e,6r)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one

(2e,4e,6r)-1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one

C21H23NO4 (353.1627)


   

8-[(1e)-2,5-dimethylhex-1-en-1-yl]-4-(hydroxymethyl)-7-methyl-9h-carbazole-1,6-diol

8-[(1e)-2,5-dimethylhex-1-en-1-yl]-4-(hydroxymethyl)-7-methyl-9h-carbazole-1,6-diol

C22H27NO3 (353.1991)


   

(3s,6z)-3-methoxy-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

(3s,6z)-3-methoxy-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

C20H23N3O3 (353.1739)


   

2-{6-[(4-hydroxy-3-methylbutyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(4-hydroxy-3-methylbutyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C15H23N5O5 (353.1699)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 4-ethyl-3-hydroxy-2,3,4-trimethyl-5-oxooxolane-2-carboxylate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 4-ethyl-3-hydroxy-2,3,4-trimethyl-5-oxooxolane-2-carboxylate

C18H27NO6 (353.1838)


   

1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraene-15,17-diol

C23H31NO2 (353.2355)


   

methyl (3z,5r,6s,10s,16r,17r)-6-methyl-20-oxo-8-azapentacyclo[11.5.1.1⁵,⁸.0²,¹⁰.0¹⁶,¹⁹]icosa-1,3,13(19)-triene-17-carboxylate

methyl (3z,5r,6s,10s,16r,17r)-6-methyl-20-oxo-8-azapentacyclo[11.5.1.1⁵,⁸.0²,¹⁰.0¹⁶,¹⁹]icosa-1,3,13(19)-triene-17-carboxylate

C22H27NO3 (353.1991)


   

2,3,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene

2,3,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene

C21H23NO4 (353.1627)


   

(6z)-3-methoxy-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

(6z)-3-methoxy-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}pyrazine-2,5-diol

C20H23N3O3 (353.1739)


   

(1r,4s,6s,16r)-6-hydroxy-6-[(1s)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4s,6s,16r)-6-hydroxy-6-[(1s)-1-hydroxyethyl]-4-isopropyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

1-[(1r,2r,4as,8as)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

1-[(1r,2r,4as,8as)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

C22H27NO3 (353.1991)


   

(1r,4z,6r,7s,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4z,6r,7s,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

(2s)-5-hydroxy-4-[(2e,4e,6e)-1-hydroxy-2,6-dimethylocta-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

(2s)-5-hydroxy-4-[(2e,4e,6e)-1-hydroxy-2,6-dimethylocta-2,4,6-trien-1-ylidene]-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one

C21H23NO4 (353.1627)


   

(5ar,11as,11bs)-2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h,11ah,11bh-naphtho[2,3-a]pyrrolizine-3,11-dione

(5ar,11as,11bs)-2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h,11ah,11bh-naphtho[2,3-a]pyrrolizine-3,11-dione

C20H23N3O3 (353.1739)


   

1-[(1s,2r)-1,2-dihydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

1-[(1s,2r)-1,2-dihydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

C21H23NO4 (353.1627)


   

4-ethylidene-7,12-dihydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

4-ethylidene-7,12-dihydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

C17H23NO7 (353.1474)


   

(1s,7r,7ar)-1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

(1s,7r,7ar)-1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

C18H27NO6 (353.1838)


   

(1s,21r)-16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene

(1s,21r)-16,17-dimethoxy-21-methyl-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15,17,19-hexaene

C21H23NO4 (353.1627)


   

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

C21H23NO4 (353.1627)


   

5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

C22H27NO3 (353.1991)


   

(1r,4z,6r,7s,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4z,6r,7s,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one

1-[2,4-dihydroxy-5-(4-hydroxyphenyl)pyridin-3-yl]-4,6-dimethylocta-2,4-dien-1-one

C21H23NO4 (353.1627)


   

(1r,4r,6r,7s,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4r,6r,7s,17r)-4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H27NO6 (353.1838)


   

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

(3e)-4-{4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl}but-3-en-2-ol

(3e)-4-{4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl}but-3-en-2-ol

C22H27NO3 (353.1991)


   

1-hydroxy-5-methoxy-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}pyrazin-2-one

1-hydroxy-5-methoxy-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}pyrazin-2-one

C20H23N3O3 (353.1739)


   

3-(1-hydroxyhexylidene)-9a-methyl-6-(prop-1-en-1-yl)furo[3,2-g]isoquinoline-2,9-dione

3-(1-hydroxyhexylidene)-9a-methyl-6-(prop-1-en-1-yl)furo[3,2-g]isoquinoline-2,9-dione

C21H23NO4 (353.1627)


   

4-ethyl-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

4-ethyl-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C18H27NO6 (353.1838)


   

(1s,5r,6s,11r,12s,14r,17s,20s,21r)-5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

(1s,5r,6s,11r,12s,14r,17s,20s,21r)-5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

C22H27NO3 (353.1991)


   

(1r,4z,6r,7r,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4z,6r,7r,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

(9s)-4,16-dimethoxy-10-(prop-2-en-1-yl)-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-5,15-diol

(9s)-4,16-dimethoxy-10-(prop-2-en-1-yl)-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-5,15-diol

C21H23NO4 (353.1627)


   

(2s,3z)-4-[(16s)-4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl]but-3-en-2-ol

(2s,3z)-4-[(16s)-4,5-dimethoxy-12-azatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9-pentaen-9-yl]but-3-en-2-ol

C22H27NO3 (353.1991)


   

1-[2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

1-[2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

C22H27NO3 (353.1991)


   

[(7r,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C17H23NO7 (353.1474)


   

3-[(1r,2s,3s)-2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

3-[(1r,2s,3s)-2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

C23H31NO2 (353.2355)


   

(2-{1,2-dimethoxy-9h-phenanthro[2,3-d][1,3]dioxol-4-yl}ethyl)dimethylamine

(2-{1,2-dimethoxy-9h-phenanthro[2,3-d][1,3]dioxol-4-yl}ethyl)dimethylamine

C21H23NO4 (353.1627)


   

3-[2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

3-[2-(1h-indol-3-ylmethyl)-2,3-dimethyl-6-(propan-2-ylidene)cyclohexyl]propanoic acid

C23H31NO2 (353.2355)


   

4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

4-ethyl-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H27NO6 (353.1838)


   

8-(2,5-dimethylhex-1-en-1-yl)-4-(hydroxymethyl)-7-methyl-9h-carbazole-1,6-diol

8-(2,5-dimethylhex-1-en-1-yl)-4-(hydroxymethyl)-7-methyl-9h-carbazole-1,6-diol

C22H27NO3 (353.1991)


   

5-hydroxy-6-methoxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazin-2-one

5-hydroxy-6-methoxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazin-2-one

C20H23N3O3 (353.1739)


   

3,4,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene

3,4,10,11-tetramethoxy-7,8-dihydro-5h-6-azatetraphene

C21H23NO4 (353.1627)


   

(1r,4z,6s,7r,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4z,6s,7r,11s,12s,17s)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H27NO6 (353.1838)


   

1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

1-({[(2z)-2-(hydroxymethyl)but-2-enoyl]oxy}methyl)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-hexahydro-1h-pyrrolizin-4-ium-4-olate

C18H27NO6 (353.1838)


   

(2r,3s,4r,5s)-2-(6-{[(3s)-4-hydroxy-3-methylbutyl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3s,4r,5s)-2-(6-{[(3s)-4-hydroxy-3-methylbutyl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H23N5O5 (353.1699)


   

1-[(2s)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

1-[(2s)-2-(2h-1,3-benzodioxol-5-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]pyrrolidine

C22H27NO3 (353.1991)


   

(8s,12ar,14as,15s,18ar,18bs)-5,15-dihydroxy-8-methyl-4h,7h,8h,12ah,14ah,15h,16h,18ah,18bh-naphtho[1,2-g]azacyclotetradecan-3-one

(8s,12ar,14as,15s,18ar,18bs)-5,15-dihydroxy-8-methyl-4h,7h,8h,12ah,14ah,15h,16h,18ah,18bh-naphtho[1,2-g]azacyclotetradecan-3-one

C22H27NO3 (353.1991)


   

(1r,3s,4s,7r,8r,11r,12s,13r)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.0³,⁷]tetradecane-4,12,13-triol

(1r,3s,4s,7r,8r,11r,12s,13r)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.0³,⁷]tetradecane-4,12,13-triol

C17H23NO7 (353.1474)


   

(2r,3s,4r)-2-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylic acid

(2r,3s,4r)-2-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3,5-dihydroxy-3-methyl-4h-pyrrole-2-carboxylic acid

C19H31NO5 (353.2202)


   

(4s,5s,6e,10e)-12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

(4s,5s,6e,10e)-12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

C23H31NO2 (353.2355)